Tandem Diabetes (TNDM) Q1 Revenues Show Beat Beat; Guides Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Tandem Diabetes Care Announces First Quarter 2019 Financial Results and Updated 2019 Financial Guidance
April 30, 2019 4:05 PM EDTSAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2019 and updated its financial guidance for the year ending December 31, 2019.
In comparing the first quarter of 2019 to the same period of 2018:
Pump shipments increased 232 percent to 14,732 pumps from 4,444 pumps Sales increased 142 percent to $66.0 million from $27.3 million Operating margin improved to negative 17 percent from negative 57 percent Adjusted EBITDA(1)... More